Evidence map›Paper›PMID 32983170›Full record

ArticleFrontiers in immunology2020

Antibacterial Fusion Proteins Enhance

Maisem Laabei, Lucie Colineau, Serena Bettoni, Karolina Maziarz, David Ermert, Kristian Riesbeck, Sanjay Ram, Anna M Blom

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Diverse Functions of C4b-Binding Protein in Health and Disease.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  3. Article
  4. NontypeableJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Maisem LaabeiDivision of Medical Protein Chemistry, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Lucie ColineauDivision of Medical Protein Chemistry, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Serena BettoniDivision of Medical Protein Chemistry, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Karolina MaziarzDivision of Medical Protein Chemistry, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
David ErmertDivision of Medical Protein Chemistry, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Kristian RiesbeckClinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Sanjay RamDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, United States.
Anna M BlomDivision of Medical Protein Chemistry, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.
Lund University · SEUniversity of Massachusetts Chan Medical School · US

Funding

Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoeaR01AI132296 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2017 to 2021
$5.5M
Immune defenses against Neisseria gonorrhoeaeR01AI114790 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAM, SANJAY, RICE, PETER A. · 2015 to 2019
$3.1M
An immunotherapeutic to prevent gonorrheaR44AI147930 · NIAID · PLANET BIOTECHNOLOGY, INC. · PI RAM, SANJAY, WYCOFF, KEITH · 2019 to 2021
$2.0M
Gonorrhea and HIV prevention with intravaginal ring drug deliveryR33AI136007 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOSS, JOHN A, RAM, SANJAY · 2020 to 2022
$1.4M
Gonorrhea and HIV prevention with intravaginal ring drug deliveryR61AI136007 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOSS, JOHN A, RAM, SANJAY · 2018 to 2019
$1.0M
NIAID NIH HHS R01 AI114790NIAID NIH HHS R01 AI132296NIAID NIH HHS R33 AI136007NIAID NIH HHS R44 AI147930NIAID NIH HHS R61 AI136007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBinding, CompetitiveBlood Bactericidal ActivityCHO CellsComplement C3bComplement C3dComplement C4b-Binding ProteinComplement Factor HCricetinaeCricetulusHumansImmunoglobulin Fc FragmentsImmunoglobulin GImmunoglobulin MMoraxella catarrhalisProtein BindingC4BPA protein, humanComplement C3bComplement C3dComplement C4b-Binding ProteinComplement Factor HImmunoglobulin Fc FragmentsImmunoglobulin GImmunoglobulin MRecombinant Fusion Proteinsantibacterialcomplementfusion proteinsMoraxella catarrhalispathogen

Identifiers

PMID32983170
PMCPMC7492680
OpenAlexW3082823815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.